ArticleCancers2025

Validation of the HFA-ICOS Score for Carfilzomib-Induced Cardiotoxicity in Multiple Myeloma: A Real-Life Perspective Study.

Anna Astarita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.